ENTRY       D10851            Mixture   Drug
NAME        Efavirenz, emtricitabine and tenofovir disoproxil;
            Atripla (TN)
PRODUCT     ATRIPLA (Gilead Sciences)
  GENERIC   EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited)
            EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Camber Pharmaceuticals)
            EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA)
            EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Laurus Labs Limited)
            EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Macleods Pharmaceuticals Limited)
            EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (REMEDYREPACK)
            EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Teva Pharmaceuticals USA)
COMPONENT   Efavirenz [DR:D00896], Emtricitabine [DR:D01199], Tenofovir disoproxil fumarate [DR:D01982]
CLASS       Antiviral
             DG03107  Anti-HIV agent
REMARK      ATC code: J05AR06
            Product: D10851<US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
                  D10851  Efavirenz, emtricitabine and tenofovir disoproxil &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Efavirenz/ Emtricitabine/ Tenofovir Disoproxil Fumarate
                D10851  Efavirenz, emtricitabine and tenofovir disoproxil
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D10851  Efavirenz, emtricitabine and tenofovir disoproxil
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D10851  Efavirenz, emtricitabine and tenofovir disoproxil
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D10851  Efavirenz, emtricitabine and tenofovir disoproxil &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10851
DBLINKS     CAS: 731772-50-2
            PubChem: 319902651
///
